, Luettgen, J., Wang, Z., Frost, C., Yones, C., Russo, C., … Frost, R. (2018). First in human study to assess safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13520 (Original work published 2018)